Robust anti-SARS-CoV2 single domain antibodies cross neutralize multiple viruses
Summary: We report robust SARS-CoV2 neutralizing sdAbs targeting the viral peptides encompassing the polybasic cleavage site (CSP) and in the receptor binding domain (RBD) of the spike (S) protein. Both the sdAbs inhibited infectivity of the CoV2 S protein expressing pseudoviruses (LV-CoV2S). Both a...
Main Authors: | Sudhakar Singh, Surbhi Dahiya, Yuviana J. Singh, Komal Beeton, Ayush Jain, Roman Sarkar, Abhishek Dubey, Azeez Tehseen, Sharvan Sehrawat |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-07-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004222008215 |
Similar Items
-
Rab8a restores diverse innate functions in CD11c+CD11b+ dendritic cells from aged mice
by: Sudhakar Singh, et al.
Published: (2024-11-01) -
Protocol for investigating the biogenesis of SARS-CoV-2 S pseudoviruses in HEK293T cells transduced to express the virus-specific intrabodies
by: Surbhi Dahiya, et al.
Published: (2023-03-01) -
Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge
by: Xiaoqing Guan, et al.
Published: (2023-10-01) -
Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domains
by: Chuan Chen, et al.
Published: (2022-08-01) -
Immunogen characterization reveals an intrinsic hindrance in eliciting neutralizing antibodies against JN.1 variant
by: Junhao Fan, et al.
Published: (2024-08-01)